Literature DB >> 28454828

Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.

Andrew P Ambrosy1, Lukasz P Cerbin2, Adam D DeVore1, Stephen J Greene1, William E Kraus1, Christopher M O'Connor3, Ileana L Piña4, David J Whellan5, Daniel Wojdyla6, Angie Wu6, Robert J Mentz7.   

Abstract

BACKGROUND: Although aerobic exercise improves quality of life as assessed by a disease-specific instrument in ambulatory HF patients with a reduced ejection fraction (EF), the impact of an exercise intervention on general health status has not been previously reported.
METHODS: A secondary analysis was performed of the HF-ACTION trial (ClinicalTrials.gov Number: NCT00047437), which enrolled 2331 medically stable outpatients with HF and an EF ≤35% and randomized them to aerobic exercise training, consisting of 36 supervised sessions followed by home-based training versus usual care for a median follow-up of 30 months. The EuroQOL 5-dimension questionnaire (EQ-5D) was administered to study participants at baseline, 3 months, and 12 months. EQ-5D includes functional dimensions (ie, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), which were mapped to corresponding utility scores (ie, 0=death and 1=perfect health), and a visual analogue scale (VAS) ranging from 0 (ie, "worst imaginable health state") to 100 (ie, "best imaginable health state").
RESULTS: Study participants had a median (25th, 75th) age of 59 (51, 68) years and 71% were male. A history of ischemic heart disease was reported in 51% of participants and the EF was 25% (20%, 30%). Baseline VAS and mapped utility scores were 65±19 and 0.81±0.14. Exercise training led to an improvement in VAS score compared with usual care from baseline to 3 months (exercise training: 6±17 vs usual care: 3±20; P <.01) although there were no further significant changes at 12 months. Aerobic exercise training did not favorably change mapped utility scores over either timeframe. After multivariable adjustment, lower mapped utility (hazard ratio [HR] 1.19 per 0.1 decrease, 95% CI 1.09-1.29; P < .0001) and VAS scores (HR 1.05 per 10 point decrease, 95% CI 1.02-1.08; P < .01) at baseline were associated with increased risk of death or hospitalization.
CONCLUSION: Ambulatory HF patients with a reduced EF had impaired health status at baseline which was associated with increased morbidity and mortality, in part mitigated by a structured aerobic exercise regimen.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28454828     DOI: 10.1016/j.ahj.2016.12.017

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

Review 1.  Adverse Remodeling and Reverse Remodeling After Myocardial Infarction.

Authors:  Ankeet S Bhatt; Andrew P Ambrosy; Eric J Velazquez
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

2.  A prospective study on sex differences in functional capacity, quality of life and prognosis in patients with heart failure.

Authors:  Yiming Ma; Yunke Shi; Wenfang Ma; Dan Yang; Zhao Hu; Mingqiang Wang; Xingyu Cao; Chaoyue Zhang; Xiang Luo; Shulin He; Min Zhang; Yong Duan; Hongyan Cai
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

3.  The effect of diet, lifestyle and psychological factors in the prognosis of ischemic heart failure.

Authors:  Maria Salourou; Stefanos Archontakis; Skevos Sideris; Ioannis Parisis; Gerasimos Siasos; Evaggelos Oikonomou; Konstantinos Mourouzis; Konstantinos Sideris; Christodoulos Stefanadis; Dimitrios Tousoulis
Journal:  Metabol Open       Date:  2019-03-13

4.  Relationship Between Praying and Self-Care in Elderly with Heart Failure: A Cross-Sectional Study in West of Iran.

Authors:  Behrang Kazeminezhad; Asma Tarjoman; Milad Borji
Journal:  J Relig Health       Date:  2020-02

Review 5.  Cardiac Rehabilitation in Older Adults with Heart Failure: Fitting a Square Peg in a Round Hole.

Authors:  Kelsey M Flint; Amy M Pastva; Gordon R Reeves
Journal:  Clin Geriatr Med       Date:  2019-07-03       Impact factor: 3.076

6.  Exercise-based cardiac rehabilitation for adults with heart failure.

Authors:  Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-01-29

7.  "As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease.

Authors:  Laurent Bailly; Philippe Mossé; Stéphane Diagana; Marion Fournier; Fabienne d'Arripe-Longueville; Odile Diagana; Jocelyn Gal; Jean Grebet; Mario Moncada; Jean-Jacques Domerego; Rémi Radel; Roxane Fabre; Alain Fuch; Christian Pradier
Journal:  BMC Cardiovasc Disord       Date:  2018-12-06       Impact factor: 2.298

8.  Effects of tailored telemonitoring on functional status and health-related quality of life in patients with heart failure.

Authors:  A J Gingele; B Ramaekers; H P Brunner-La Rocca; G De Weerd; J Kragten; V van Empel; K van der Weg; H J M Vrijhoef; A Gorgels; G Cleuren; J J J Boyne; C Knackstedt
Journal:  Neth Heart J       Date:  2019-11       Impact factor: 2.380

Review 9.  An "Exercise" in Cardiac Metabolism.

Authors:  Stephen C Kolwicz
Journal:  Front Cardiovasc Med       Date:  2018-06-07

10.  The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.

Authors:  Hasnain M Dalal; Rod S Taylor; Kate Jolly; Russell C Davis; Patrick Doherty; Jackie Miles; Robin van Lingen; Fiona C Warren; Colin Green; Jennifer Wingham; Colin Greaves; Susannah Sadler; Melvyn Hillsdon; Charles Abraham; Nicky Britten; Julia Frost; Sally Singh; Christopher Hayward; Victoria Eyre; Kevin Paul; Chim C Lang; Karen Smith
Journal:  Eur J Prev Cardiol       Date:  2018-10-10       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.